Free Trial
NASDAQ:XXII

22nd Century Group (XXII) Stock Price, News & Analysis

$0.78
+0.06 (+8.33%)
(As of 07/26/2024 ET)
Today's Range
$0.69
$0.78
50-Day Range
$0.59
$1.40
52-Week Range
$0.58
$63.84
Volume
165,767 shs
Average Volume
822,368 shs
Market Capitalization
$6.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$100.00

22nd Century Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
12,720.5% Upside
$100.00 Price Target
Short Interest
Healthy
2.80% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.44mentions of 22nd Century Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$9,810 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.81 out of 5 stars

XXII stock logo

About 22nd Century Group Stock (NASDAQ:XXII)

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

XXII Stock Price History

XXII Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Here's what to expect from 22nd Century Group's earnings
22nd Century Q1 Earnings Preview
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
22nd Century Group Inc
Notable earnings before Thursday's open
See More Headlines
Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/26/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Employees
80
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$100.00
High Stock Price Target
$120.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+12,720.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-140,770,000.00
Net Margins
-233.06%
Pretax Margin
-89.46%

Debt

Sales & Book Value

Annual Sales
$32.20 million
Book Value
($3.09) per share

Miscellaneous

Free Float
8,259,000
Market Cap
$6.47 million
Optionable
Optionable
Beta
1.37
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

XXII Stock Analysis - Frequently Asked Questions

How have XXII shares performed this year?

22nd Century Group's stock was trading at $47.6672 at the beginning of 2024. Since then, XXII stock has decreased by 98.4% and is now trading at $0.78.
View the best growth stocks for 2024 here
.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) released its quarterly earnings results on Wednesday, May, 15th. The biotechnology company reported ($1.72) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($5.28) by $3.56. The biotechnology company had revenue of $6.47 million for the quarter, compared to analyst estimates of $7.86 million. 22nd Century Group had a negative trailing twelve-month return on equity of 380.39% and a negative net margin of 233.06%.

When did 22nd Century Group's stock split?

22nd Century Group shares reverse split on the morning of Tuesday, April 2nd 2024. The 1-16 reverse split was announced on Tuesday, April 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH) and Inseego (INSG).

This page (NASDAQ:XXII) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners